These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11266412)

  • 1. Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales.
    Johnson AP; Warner M; George RC; Livermore DM
    J Antimicrob Chemother; 2001 Apr; 47(4):411-5. PubMed ID: 11266412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.
    Black J; Moland ES; Chartrand SA; Thomson KS
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):195-7. PubMed ID: 11337189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Austrian Bacterial Surveillance Network.
    Buxbaum A; Straschil U; Moser C; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():13-8. PubMed ID: 10382870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis.
    Tarasi A; Capone A; Tarasi D; Cassone M; Bianco G; Venditti M
    J Antimicrob Chemother; 1999 Jun; 43(6):833-5. PubMed ID: 10404324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrument.
    Jorgensen JH; Crawford SA; McElmeel LM; Whitney CG
    J Clin Microbiol; 2004 Dec; 42(12):5928-30. PubMed ID: 15583344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.
    Reinert RR; Schlaeger JJ; Lütticken R
    J Antimicrob Chemother; 1998 Dec; 42(6):803-6. PubMed ID: 10052905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance.
    Johnson AP; Warner M; Livermore DM
    Int J Antimicrob Agents; 2001 May; 17(5):377-81. PubMed ID: 11337224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L; Manzor O; Check C; Pawlak J; Belian B
    J Antimicrob Chemother; 2001 Jun; 47(6):875-7. PubMed ID: 11389122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.
    Pestova E; Millichap JJ; Noskin GA; Peterson LR
    J Antimicrob Chemother; 2000 May; 45(5):583-90. PubMed ID: 10797078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin.
    Klugman KP; Capper T
    J Antimicrob Chemother; 1997 Dec; 40(6):797-802. PubMed ID: 9462430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumococcus and quinolone resistance].
    Bello S; Torres A
    Arch Bronconeumol; 2003 Mar; 39(3):97-100. PubMed ID: 12622966
    [No Abstract]   [Full Text] [Related]  

  • 14. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
    Esposito S; Noviello S; Ianniello F
    J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
    Rubinstein E; Diamantstein L; Yoseph G; Gruzman G; Rubinovitch B; Barzilai A; Keller N
    Clin Microbiol Infect; 2000 Dec; 6(12):678-81. PubMed ID: 11284929
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae.
    Weiss K; Laverdiere M; Restieri C
    J Antimicrob Chemother; 1998 Oct; 42(4):523-5. PubMed ID: 9818753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
    Pong A; Thomson KS; Moland ES; Chartrand SA; Sanders CC
    J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain.
    Alós JI; Oteo J; Aracil B; Gómez-Garcés JL
    J Antimicrob Chemother; 2001 Jul; 48(1):145-8. PubMed ID: 11418530
    [No Abstract]   [Full Text] [Related]  

  • 19. Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.
    Clark CL; Nagai K; Davies TA; Bozdogan B; Dewasse B; Jacobs MR; Appelbaum PC
    Clin Microbiol Infect; 2002 Jun; 8(6):373-80. PubMed ID: 12084107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.
    Boswell FJ; Andrews JM; Wise R
    J Antimicrob Chemother; 2001 Sep; 48(3):446-7. PubMed ID: 11533016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.